Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$6.16 - $9.6 $2,248 - $3,504
-365 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$8.12 - $15.72 $3,418 - $6,618
-421 Reduced 53.56%
365 $3,000
Q1 2019

May 13, 2019

SELL
$15.58 - $20.01 $1,184 - $1,520
-76 Reduced 8.82%
786 $12,000
Q4 2018

Feb 08, 2019

SELL
$14.59 - $23.84 $714 - $1,168
-49 Reduced 5.38%
862 $13,000
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $168 - $205
8 Added 0.89%
911 $20,000
Q2 2018

Aug 10, 2018

BUY
$16.77 - $24.71 $1,911 - $2,816
114 Added 14.45%
903 $22,000
Q1 2018

May 14, 2018

SELL
$16.68 - $22.07 $2,552 - $3,376
-153 Reduced 16.24%
789 $13,000
Q4 2017

Feb 09, 2018

BUY
$11.23 - $19.1 $9,680 - $16,464
862 Added 1077.5%
942 $18,000
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $1,232 - $2,573
80
80 $1,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.